In vitro Transcription and Capping of Gaussia Luciferase mRNA Followed by HeLa Cell Transfection

Overview

This method describes the high yield in vitro synthesis of capped and uncapped mRNA from a linearized plasmid containing the Gaussia luciferase (GLuc) gene. The synthesized RNA is purified, and a fraction of the uncapped RNA is enzymatically capped using the Vaccinia virus capping enzyme before transfection into HeLa cells for luciferase activity assay.

Key Study Components

Area of Science

• Neuroscience
• Cell Biology
• Molecular Biology

Background

• In vitro transcription is a method to produce RNA from DNA templates.
• Capped mRNA is essential for stability and translation efficiency.
• Gaussia luciferase serves as a reporter for assessing mRNA functionality.
• HeLa cells are commonly used for transfection studies.

Purpose of Study

• To synthesize both capped and uncapped mRNA transcripts of the GLuc gene.
• To compare luciferase activity from capped versus uncapped mRNA in HeLa cells.
• To demonstrate the efficiency of the T7 high yield RNA synthesis kit.

Methods Used

• In vitro transcription using a T7 RNA polymerase kit.
• Enzymatic capping of uncapped RNA using Vaccinia virus capping enzyme.
• Transfection of synthesized mRNA into HeLa cells.
• Luciferase activity assay to measure the expression of GLuc.

Main Results

• Successful synthesis of high-quality capped and uncapped mRNA.
• Demonstrated differences in luciferase activity between capped and uncapped mRNA.
• Validated the use of the T7 high yield RNA synthesis kit for producing full-length RNA transcripts.
• Provided insights into RNA transfection methodologies.

Conclusions

• The method effectively synthesizes and transfects mRNA into HeLa cells.
• Capping improves the stability and translation of mRNA.
• This approach can be applied to various RNA applications beyond luciferase assays.

Frequently Asked Questions